On June 12, 2025, GSK plc purchased 317,488 ordinary shares at an average price of 1,545.55p as part of its ongoing buyback program, totaling 2,454,275 shares bought since June 4, 2025. The company holds 220,588,658 shares in treasury and has 4,094,694,253 shares issued, equating to 5.39% voting rights held in treasury.